Raw Materials

Over the last 3 years European pharmaceutical industry has seen a general slowdown in bringing new drugs to market. Leading European drug companies are now being forced to look for new partners when it comes to their R&D activities or even raw material supplies to reduce costs and remain competitive with US and Asia.

In the current European climate it is absolutely crucial for raw material manufacturers to concentrate on building strong relationships with pharmaceutical customers in order to secure steady business from them.

Next Generation Pharmaceutical will be addressing the purchasing and compliant issues that European Pharmaceutical companies are currently facing and looking in depth at the controversial REACH regulation that remains a sore point in European chemicals industry.

Focus Issues

-REACH legislation
-Fine chemicals
-Manufacturing services
-API Development
-Peptide chemistry
-Protein manufacture
-Amino acids
-Testing and inspections
-Intermediates